Let's look at a possible NASDAQ micro cap for AMBS
Post# of 30066
Posted On: 08/10/2014 11:17:02 AM
Let's look at a possible NASDAQ micro cap for AMBS to acquire--
13million market cap
in Amarantus's backyard
2 drugs in phase 3 trials
Threshold Pharmaceuticals Inc. (THLD)
Overview
Threshold is a biotechnology company focused on the discovery and development of therapeutics for the potential treatment of cancer. By selectively targeting abnormally-proliferating tumor cells, the Company's drug candidates are designed to be potentially more effective and less toxic to healthy tissues than conventional treatments. For additional information, please visit our website (http://www.thresholdpharm.com).
Contact Information
1300 Seaport Boulevard
5th Floor
Redwood City, CA 94063
Stock
Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $13.1M
*************************************************************************************American Bio Medica Corp. (ABMC)
Overview
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen®, Rapid One, Rapid TEC®, RDS® InCup® and Rapid TOX products test for the presence or absence of drugs of abuse in urine, while OralStat® tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader® is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.
*
Stock
Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $14.3M
13million market cap
in Amarantus's backyard
2 drugs in phase 3 trials
Threshold Pharmaceuticals Inc. (THLD)
Overview
Threshold is a biotechnology company focused on the discovery and development of therapeutics for the potential treatment of cancer. By selectively targeting abnormally-proliferating tumor cells, the Company's drug candidates are designed to be potentially more effective and less toxic to healthy tissues than conventional treatments. For additional information, please visit our website (http://www.thresholdpharm.com).
Contact Information
1300 Seaport Boulevard
5th Floor
Redwood City, CA 94063
Stock
Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $13.1M
*************************************************************************************American Bio Medica Corp. (ABMC)
Overview
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen®, Rapid One, Rapid TEC®, RDS® InCup® and Rapid TOX products test for the presence or absence of drugs of abuse in urine, while OralStat® tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader® is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.
*
Stock
Exchange: NASDAQ
Industry: Diagnostic Substances
Market Cap: $14.3M
(0)
(0)